The University of California, Irvine Cancer Center is a matrix-type organization administratively housed in the College of Medicine. The research goals of the Cancer Center are: 1) To contribute to understanding of the basic mechanisms that underlie the phenotype and genotype of cancer; 2) To facilitate the translation of laboratory and epidemiologic research into hypothesis-driven clinical prevention and treatment studies; 3) To conduct clinical prevention and treatment trials, whenever possible emanating from research generated in the Center; 4) To accrue patients to cooperative group and high priority trials; 5) To define cancer risk in the diverse socioeconomic and multicultural society served by the Center and to develop research strategies to facilitate the prevention and early detection of cancer in these populations; and 6) To utilize the extensive education and training opportunities available at all levels as a major translational vehicle and to encourage activities that promote interdisciplinary research. The Cancer Center serves over 5 million people in Orange, Riverside, and San Bernardino Counties in California. The 105 full members of the Center are supported by over $14 million (annual direct costs) including over $11 million in peer-reviewed grants and contracts directly related to the cancer problem. Cancer Center members enter over 150 patients on cancer clinical trials annually. An extensive community research network has been established in the Southern California region and beyond, which involves over 20 separate sites. A Clinical Trials Protocol Review and Monitoring System has been instituted as well. The Center is organized into four major divisions: Basic Sciences, Clinical Sciences, Cancer Control Research, and Education and Training. The divisions interact through seven research programs: Carcinogenesis, Growth Factors and Signaling, Structural Molecular Biology, Virology, Clinical Oncology, Photomedicine, and Prevention and Epidemiology. The Center will provide centralized support for these program functions through six shared resource facilities: Biostatistics, Clinical Investigations, Human Tumor Tissue, Immunology, Molecular Biology, and Optical Biology. The Education and Training Division facilitates integration of students into basic, clinical, and control research activities in the various programs and accordingly enhances the translational capabilities of the Center. Development funds will be used to recruit faculty in areas of research the Center has identified as high priority and to provide seed grants that will support collaborative translational cancer research of Center members. The primary planning and operational research decisions of the Center will be made by the Management Committee, which consists of the Director, Associate Directors, Program Leaders, Shared Resource Directors, Standing Committee Chairs, and Clinical Division Chiefs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
1P30CA062203-01
Application #
2103284
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1994-08-15
Project End
1997-07-31
Budget Start
1994-08-15
Budget End
1995-07-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Wang, Yajun; Ngor, Arlene K; Nikoomanzar, Ali et al. (2018) Evolution of a General RNA-Cleaving FANA Enzyme. Nat Commun 9:5067
Qiu, Xiaolong; Lombardo, Jeremy A; Westerhof, Trisha M et al. (2018) Microfluidic filter device with nylon mesh membranes efficiently dissociates cell aggregates and digested tissue into single cells. Lab Chip 18:2776-2786
Patterson, Kurt; Yu, James; Landberg, Jenny et al. (2018) Functional genomics for the oleaginous yeast Yarrowia lipolytica. Metab Eng 48:184-196
Lee, J Scott; Roberts, Andrew; Juarez, Dennis et al. (2018) Statins enhance efficacy of venetoclax in blood cancers. Sci Transl Med 10:
Sierra, Robert A; Hoverter, Nathan P; Ramirez, Ricardo N et al. (2018) TCF7L1 suppresses primitive streak gene expression to support human embryonic stem cell pluripotency. Development 145:
Maciejewski, Sonia; Ullmer, Wendy; Semler, Bert L (2018) VPg unlinkase/TDP2 in cardiovirus infected cells: Re-localization and proteolytic cleavage. Virology 516:139-146
Konstorum, Anna; Lowengrub, John S (2018) Activation of the HGF/c-Met axis in the tumor microenvironment: A multispecies model. J Theor Biol 439:86-99
Yan, Huaming; Konstorum, Anna; Lowengrub, John S (2018) Three-Dimensional Spatiotemporal Modeling of Colon Cancer Organoids Reveals that Multimodal Control of Stem Cell Self-Renewal is a Critical Determinant of Size and Shape in Early Stages of Tumor Growth. Bull Math Biol 80:1404-1433
Wang, Xiaolin; Zhao, Da; Phan, Duc T T et al. (2018) A hydrostatic pressure-driven passive micropump enhanced with siphon-based autofill function. Lab Chip 18:2167-2177
Flather, Dylan; Nguyen, Joseph H C; Semler, Bert L et al. (2018) Exploitation of nuclear functions by human rhinovirus, a cytoplasmic RNA virus. PLoS Pathog 14:e1007277

Showing the most recent 10 out of 1106 publications